GlassScriptPhysician profile
Anthony J Popek
NPI 1083619183
$5,874.95
in general payments reported to CMS, 2019-2025
45 companies · $647 in 2025
The $647 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $714 · 2020: $764 · 2021: $984 · 2022: $929 · 2023: $926 · 2024: $910 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,482.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,166.96 | 2019-2025 | Farxiga, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $773.66 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $594.59 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $467.31 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $348.76 | 2019-2023 | Vpriv, Trintellix |
| Amarin Pharma, INC. | $317.79 | 2019-2022 | |
| Pfizer INC. | $222.83 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $196.85 | 2019-2025 | Lagevrio, Gardasil 9, Capvaxive |
| Amgen INC. | $195.64 | 2019-2025 | Repatha, Krystexxa, Otezla |
| Exact Sciences Corporation | $148.13 | 2023-2025 | Cologuard Collection Kit |
| Eisai INC. | $119.89 | 2020-2021 | |
| Abbott Laboratories | $119.49 | 2022-2024 | Proclaim |
| Abbvie INC. | $92.69 | 2019-2022 | |
| Medtronic, INC. | $87.61 | 2024 | Venaseal |
| Astellas Pharma US INC | $78.50 | 2023-2024 | Veozah, Myrbetriq |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Popek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.